Biotech Firm Develops Pennycress as the Next Cash Crop
February 25, 2015| |
A young biotech firm known as Arvegenix is working on field pennycress (Thlaspi arvense) as a viable commodity crop for farmers using advanced breeding technology. Pennycress seeds contain 36% oil, about twice the amount of oil in soybean. Pennycress oil has properties suitable for biodiesel and aviation fuel.
After oil extraction, the leftover meal can be used for livestock feed production. Thus, Arvegenix researchers are developing new varieties of the plant to make it more predictable, more consistent, and with more oil yield.
Arvegenix aims to add revenue to corn and soybean farmers by planting pennycress during winter. "If we can fit into that window when nothing else is growing, that's the definition of sustainability," Arvegenix CEO Jerry Steiner said.
| |
Biotech Updates is a weekly newsletter of ISAAA, a not-for-profit organization. It is distributed for free to over 22,000 subscribers worldwide to inform them about the key developments in biosciences, especially in biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
-
See more articles:
-
News from Around the World
- FAO DG: Agri Production Must Change
- Paterson Presents ISAAA Report in Pretoria, SA
- Biotech Firm Develops Pennycress as the Next Cash Crop
- ASA Calls on EU to Issue Import Approvals for 13 Biotech Traits
- Scientists Identify Gene that Could Prevent Cross-pollination
- New Hybrid Maize Launched in Pakistan
- Australian Researchers Develop Salt Tolerant Wheat
- New Agri-tech Center to Tackle Global Plant and Soil Challenges
-
Research Highlights
- Response of GM Maize (DKC6575) Under Drought
- Arabidopsis' ACB Proteins Play Roles in Pollen Development
-
Beyond Crop Biotech
- Bladderwort's Genome Examined
- Two New Molecular Tools for the Study of the Green Alga Volvox carteri
- Scientists Map Human Epigenome
-
Announcements
- ACB 2015
- The Plant Genomics Congress Asia
-
Read the latest: - Biotech Updates (April 17, 2024)
- Gene Editing Supplement (April 10, 2024)
- Gene Drive Supplement (February 22, 2023)
-
Subscribe to BU: - Share
- Tweet